Re-appointment of MD and CEO Mr. Aalap Prajapati for 3 years

Management Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.3%Reaction day

₹35.67

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+5.0% vs market

Pharmaceuticals peers, median of 176sector-0.2%+5.5% vs sector

On the reaction day the stock moved 5.0 pts more than Nifty Microcap 250 and 5.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.3+0.3+5.0-0.2+5.5

Next day

+2.1-0.2+2.3-0.5+2.5

+5.1+0.4+4.7-0.1+5.2

+6.4+0.2+6.2-0.0+6.4

+11.0+0.5+10.5+0.5+10.5

+8.1+0.8+7.3+0.5+7.6

+9.3-0.8+10.1+0.7+8.6

15d

+14.9-2.1+17.0+0.2+14.7

+0.9+0.2+0.7+2.1-1.2

+8.5-9.2+17.6-6.7+15.1

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 176Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Gujarat Terce Laboratories shareholders at the 41st AGM on 21 Aug 2026 approved the re-appointment of Mr. Aalap Prajapati as Managing Director and CEO for three years, from 28 October 2026 to 27 October 2029. He has over 15 years of pharmaceutical industry experience and is the son of Whole-Time Director Mr. Natwarbhai Prajapati.

Likely market impact

Leadership continuity for three more years; routine re-appointment, no major share price trigger expected.